Tekamlo is a combination medication that contains two active ingredients, aliskiren and amlodipine. Aliskiren is a direct renin inhibitor, while amlodipine is a calcium channel blocker. Together, these two medications work synergistically to lower blood pressure in patients with hypertension.

Aliskiren works by blocking the enzyme renin, which is responsible for initiating a cascade of events that ultimately lead to increased blood pressure. By inhibiting renin, aliskiren helps to relax blood vessels and reduce the overall resistance in the arteries, leading to a decrease in blood pressure.

Amlodipine, on the other hand, works by blocking calcium channels in the blood vessels and heart muscle. This action results in the relaxation of blood vessels and improved blood flow, further contributing to the lowering of blood pressure.

Tekamlo is typically prescribed for patients who have not achieved adequate blood pressure control with either aliskiren or amlodipine alone. By combining these two medications into one convenient pill, Tekamlo offers a comprehensive approach to managing hypertension and reducing the risk of cardiovascular events.

As with any medication, it is important to follow your healthcare provider’s instructions carefully and report any side effects or concerns. Common side effects of Tekamlo may include dizziness, headache, and swelling in the ankles or feet. It is also important to monitor your blood pressure regularly while taking Tekamlo to ensure that it is effectively controlling your hypertension.

Overall, Tekamlo is a valuable treatment option for patients with hypertension, offering a convenient and effective way to manage blood pressure and reduce the risk of cardiovascular complications.